Retrospective Study
Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy

World J Exp Med
11(2):17-29.
Published online Mar 20, 2021.
doi: 10.5493/wjem.v11.i2.17
Abstract (679)
|
Core Tip (575)
|
Article Highlights (591)
|
Full Article (HTML) (3605)
|
Figures (1-3) (218)
|
Tables (1-9) (222)
|
Full Article (PDF)-994K (242)
|
Full Article (Word)-255K (158)
|
Audio-3776K (7)
|
Peer-Review Report-297K (114)
|
Answering Reviewers-110K (102)
|
Received: 12/24/2020
|
Revised: 02/19/2021
|
Accepted: 03/12/2021
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (10581)
|
Similar Articles (32)
|
Timeline of Article Publication (0)
|
Authors Evaluation (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open